A sensitivity analysis focused only on four studies reporting adjusted effect estimates, including 793 exposed and 488,871 comparator pregnancies, produced similar findings (OR 1.40
Can help break through weight loss plateaus that often occur with diet and exercise alone Recent clinical trials have shown that GLP-1 agonists can help patients lose 10-15% of their body weight on average, especially when combined with lifestyle changes
Some individuals develop: Orthostatic intolerance Heart rate variability changes Postural Orthostatic Tachycardia Syndrome (POTS)-like symptoms Temperature dysregulation (19) These patterns reflect neuroimmune interaction rather than isolated cardiac pathology
Mutant p53-associated molecular mechanisms of ros regulation in cancer cells
In: Textbook of Natural Medicine, 4th ed
Until POD5, GLP-1 level of patients with PHLF seem to recover to baseline levels (Fig